Ian Barr

Burden of influenza B virus infection and considerations for clinical management

Hassan Zaraket, Aeron C Hurt, Barry Clinch, Ian Barr, Nelson Lee

Journal article  |  2021  |  Antiviral Research

Influenza B viruses cause significant morbidity and mortality, particularly in children, but the awareness of their impact is ofte..

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020

Sheena G Sullivan, Sandra Carlson, Allen C Cheng, Monique BN Chilver, Dominic E Dwyer, Melissa Irwin, Jen Kok, Kristine Macartney, Jennifer MacLachlan, Cara Minney-Smith, David Smith, Nigel Stocks, Janette Taylor, Ian G Barr

Journal article  |  2020  |  Eurosurveillance

The coronavirus disease pandemic was declared in March 2020, as the southern hemisphere's winter approached. Australia expected co..

Variation by lineage in serum antibody responses to influenza B virus infections

Yiu Chung Lau, Ranawaka APM Perera, Vicky J Fang, Long Hei Luk, Daniel KW Chu, Peng Wu, Ian G Barr, JS Malik Peiris, Benjamin J Cowling

Journal article  |  2020  |  PLoS One

Two lineages of influenza B virus currently co-circulate and have distinct antigenicity, termed Victoria and Yamagata after the B/..

New Technologies for Influenza Vaccines

Steven Rockman, Karen L Laurie, Simone Parkes, Adam Wheatley, Ian G Barr

Journal article  |  2020  |  Microorganisms

Vaccine development has been hampered by the long lead times and the high cost required to reach the market. The 2020 pandemic, ca..

Clinical characteristics, predictors, and performance of case definition-Interim results from the WHO global respiratory syncytial virus surveillance pilot

Siddhivinayak Hirve, Nigel Crawford, Rakhee Palekar, Wenqing Zhang

Journal article  |  2020  |  Influenza and Other Respiratory Viruses

BACKGROUND: The lack of a uniform surveillance case definition poses a challenge to characterize the epidemiology, clinical featur..

Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial

Benjamin J Cowling, Ranawaka APM Perera, Sophie A Valkenburg, Nancy HL Leung, A Danielle Iuliano, Yat Hung Tam, Jennifer HF Wong, Vicky J Fang, Athena PY Li, Hau Chi So, Dennis KM Ip, Eduardo Azziz-Baumgartner, Alicia M Fry, Min Z Levine, Shivaprakash Gangappa, Suryaprakash Sambhara, Ian G Barr, Danuta M Skowronski, JS Malik Peiris, Mark G Thompson

Journal article  |  2020  |  Clinical Infectious Diseases

BACKGROUND: Enhanced influenza vaccines may improve protection for older adults, but comparative immunogenicity data are limited. ..

Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution

John Huddleston, John R Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E Wentworth, Lynne Whittaker, Burcu Ermetal, Rodney Stuart Daniels, John W McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Ian Barr, Kanta Subbarao, Pierre Barrat-Charlaix, Richard A Neher, Trevor Bedford

Journal article  |  2020  |  eLife

Seasonal influenza virus A/H3N2 is a major cause of death globally. Vaccination remains the most effective preventative. Rapid mut..

Immunogenicity of the inactivated influenza vaccine in children who have undergone autologous stem cell transplant

Anne L Ryan, Ushma D Wadia, Peter Jacoby, Laurence C Cheung, Fiona Kerr, Chris Fraser, Heather Tapp, Louise A Carolan, Karen L Laurie, Ian G Barr, Christopher C Blyth, Nicholas G Gottardo, Peter C Richmond, Rishi S Kotecha

Journal article  |  2020  |  Bone Marrow Transplantation

Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir

Danielle Tilmanis, Paulina Koszalka, Ian G Barr, Jean-Francois Rossignol, Edin Mifsud, Aeron C Hurt

Journal article  |  2020  |  Antiviral Research

A major limitation of the currently available influenza antivirals is the potential development of drug resistance. The adamantane..

Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17

Sandra Jackson, Teresa CT Peret, Thedi T Ziegler, Natalie J Thornburg, Terry Besselaar, Shobha Broor, Ian Barr, Elsa Baumeister, Mandeep Chadha, Malinee Chittaganpitch, Badarch Darmaa, Joanna Ellis, Rodrigo Fasce, Belinda Herring, Kadjo Herve, Siddhivinayak Hirve, Yan Li, Maria Pisareva, Ann Moen, Amel Naguib, et al.

Journal article  |  2020  |  Influenza and Other Respiratory Viruses